Hugh Black
Pediatric Pulmonology · Charlotte, NCNPI 1427164904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Sanofi at 37.3% of the total. 2025 is the largest year on record at $938, 4.1 times the $228 reported in 2019.
Across 101 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$960
- Regeneron Healthcare Solutions, Inc.$340
- Novartis$248
- Integra Lifesciences Corporation$150
- Aerin Medical Inc.$119
- Kaleo, Inc.$106
- plus $655 from 22 others
Across 44 payments — averaging $12,592 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$473K
- GSK$51K
- Gilead$28K
- Novartis$2K
What the payments were for
- Food & beverage$2,577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 31 | $960 |
| Regeneron Healthcare Solutions, Inc. | 14 | $340 |
| Novartis | 15 | $248 |
| Integra Lifesciences Corporation | 1 | $150 |
| Aerin Medical Inc. | 1 | $119 |
| Kaleo, Inc. | 6 | $106 |
| AbbVie | 5 | $72 |
| Insmed, Inc. | 1 | $61 |
| Genentech USA, Inc. | 2 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $48 |
| Pfizer | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| GSK | 2 | $37 |
| Merck | 2 | $36 |
| Philips North America LLC | 2 | $32 |
| AstraZeneca | 2 | $30 |
| CSL Behring | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| USWM, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Covis Pharma GmbH | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$240
- Acclarent Aera$150
- Inspira Air$150
- RELIEVA SPINPLUS NAV$150
- TruDi Probe$150
- VIVAER STYLUS$119
- RHINAER STYLUS$119
How this compares
$2,577 in reported general payments places this provider in the 85th percentile of 37 pediatric pulmonology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Charlotte
- William AsheCharlotte$6K
- Ashley ChadhaCharlotte$5K
- Marc ChesterCharlotte$1K
- Maxine EikaniCharlotte$722
- Rosemary MegalaaCharlotte$579
- Jeffrey ClearyCharlotte$455
- Dennis SchellhaseCharlotte$230
- Shean AujlaCharlotte$208
- Robert GardnerCharlotte$201
- Robert TillmanCharlotte$115
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.